E2007-G000-410: Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized

Grants and Contracts Details

StatusFinished
Effective start/end date8/20/182/10/21

Funding

  • Eisai Incorporated: $16,062.00